As of November 6, 2026, Camp4 Therapeutics Corp is a publicly traded company (Nasdaq: CAMP). The largest holder reporting an active stake on Schedule 13D is 5AM Ventures VI, L.P., at 9.9%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Janus Henderson (12.2%), Fidelity (FMR) (7.8%), Vivo Opportunity Fund Holdings, L.P. (7.4%) (Schedule 13D/A, August 31, 2026).
Is this your company?
About to sign with, pay or invest in Camp4 Therapeutics Corp? See the free Snapshot first.
Free to see. No signup.
Is Camp4 Therapeutics Corp a real, registered company?
- Camp4 Therapeutics Corp files with the SEC under CIK 1736730 (its SEC filings).
- Its shares are listed under the ticker CAMP on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Watertown, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under CAMP4 THERAPEUTICS CORP in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Fidelity (FMR) (filed 2026-11-05).
Who are Camp4 Therapeutics Corp's owners and officers?
Camp4 Therapeutics Corp: incorporated in Delaware; business address in Watertown, Massachusetts; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-11-05).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-11-05 | Fmr LLC | 7.8% |
| Schedule 13D/A, 2026-08-31 | 5am Ventures Vi, L.P. | 9.9% |
| Schedule 13D/A, 2026-08-19 | Polaris Management Co. Vii, L.L.C. | 6.3% |
| Schedule 13G/A, 2026-08-14 | Balyasny Asset Management L.P. | 4.99% |
| Schedule 13G, 2026-08-10 | Trails Edge Capital Partners, LP | 6% |
| Schedule 13D/A, 2026-08-05 | 5am Ventures Vi, L.P. | 9.9% |
| Schedule 13G, 2026-05-15 | Balyasny Asset Management L.P. | 5.07% |
| Schedule 13D/A, 2026-03-11 | Enavate Sciences Gp, LLC | 4.8% |
| Schedule 13G/A, 2026-02-13 | Vivo Opportunity Fund Holdings, L.P. | 7.4% |
| Schedule 13G/A, 2026-02-05 | Fmr LLC | 9.5% |
| Schedule 13G, 2026-01-08 | Janus Henderson Group PLC | 12.2% |
| Schedule 13D/A, 2025-12-23 | Enavate Sciences Gp, LLC | 6% |
Questions about who owns Camp4 Therapeutics Corp
Who owns Camp4 Therapeutics Corp?
On this page, 6 holders' latest ownership filings report 5% or more of Camp4 Therapeutics Corp: Janus Henderson Group PLC (12.2%, Schedule 13G, filed 2026-01-08), 5am Ventures Vi, L.P. (9.9%, Schedule 13D/A, filed 2026-08-31), Fmr LLC (7.8%, Schedule 13G/A, filed 2026-11-05), Vivo Opportunity Fund Holdings, L.P. (7.4%, Schedule 13G/A, filed 2026-02-13) and Polaris Management Co. Vii, L.L.C. (6.3%, Schedule 13D/A, filed 2026-08-19); 1 more is listed above.
Who are the largest shareholders of Camp4 Therapeutics Corp?
By the share each holder's latest filing reports, the largest holders of Camp4 Therapeutics Corp on this page are Janus Henderson Group PLC (12.2%), 5am Ventures Vi, L.P. (9.9%) and Fmr LLC (7.8%).
When did Janus Henderson Group PLC buy into Camp4 Therapeutics Corp?
The filings give report dates, not purchase dates. The earliest filing from Janus Henderson Group PLC on this page is the Schedule 13G, filed 2026-01-08, reporting 12.2%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Camp4 Therapeutics Corp?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Camp4 Therapeutics Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Camp4 Therapeutics Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
18 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Camp4 Therapeutics Corp shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- 5AM Ventures VI, L.P., a 10% owner: 5,869,091 shares (9.4% of shares outstanding), held indirectly through By 5AM Ventures VII, L.P. and 2 others, on a joint filing (Form 4, 2025-09-15).
- , a 10% owner: 5,869,091 shares (9.4% of shares outstanding), held indirectly through By 5AM Ventures VII, L.P. and 2 others, on a joint filing (Form 4, 2025-09-15).
- 5AM Opportunities II, L.P., a 10% owner: 5,869,091 shares (9.4% of shares outstanding), held indirectly through By 5AM Ventures VII, L.P. and 2 others, on a joint filing (Form 4, 2025-09-15).
- 5AM Opportunities II (GP), LLC, a 10% owner: 5,869,091 shares (9.4% of shares outstanding), held indirectly through By 5AM Ventures VII, L.P. and 2 others, on a joint filing (Form 4, 2025-09-15).
- 5AM Partners VI, LLC, a 10% owner: 5,869,091 shares (9.4% of shares outstanding), held indirectly through By 5AM Ventures VII, L.P. and 2 others, on a joint filing (Form 4, 2025-09-15).
Shares outstanding: 62,754,200 as of 2026-11-04, from the company's latest SEC cover page.
How much has Camp4 Therapeutics Corp raised?
Latest IPO step: Camp4 Therapeutics Corp filed its final IPO prospectus, ticker CAMP (424B4, 2024-10-11).
IPO filings: 424B4, 2024-10-11, S-1/A, 2024-10-07, S-1/A, 2024-09-26, S-1, 2024-09-20; ticker CAMP on Nasdaq Global Market.
Keep reading
More on Camp4 Therapeutics Corp and the records around it.
Camp4 Therapeutics Corp elsewhere on the record
- 5%+ stake filings Nov 2026
Companies that share a holder
- AH Bio Fund I, L.P. also filed stake reports on 1 other company: Freenome, Inc. (Jul 2026)
- 5AM Ventures VI, L.P. also filed stake reports on 2 other companies: ARTIVA BIOTHERAPEUTICS, INC. (Aug 2026), VOR BIOPHARMA INC. (Jul 2025)
- Enavate Sciences GP, LLC also filed stake reports on 2 other companies: Zenas BioPharma, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/camp4-therapeutics